Rockefeller Capital Management L.P. - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 35 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2022$0
-100.0%
1,5000.0%0.00%
Q3 2022$1,0000.0%1,500
+25.0%
0.00%
Q2 2022$1,000
-75.0%
1,200
+9.1%
0.00%
Q1 2022$4,000
-20.0%
1,100
+57.1%
0.00%
Q4 2021$5,0007000.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 78,115$294,0000.05%
Shaolin Capital Management LLC 275,000$1,034,0000.03%
Spectrum Management Group, LLC 5,030$19,0000.00%
Veritable, L.P. 43,551$164,0000.00%
ALPS ADVISORS INC 45,083$170,0000.00%
ETF MANAGERS GROUP, LLC 13,187$34,0000.00%
Qube Research & Technologies Ltd 24,179$91,0000.00%
NORTHERN TRUST CORP 44,476$167,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 301,110$1,132,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders